BBGSX
Price
$18.15
Change
+$0.16 (+0.89%)
Updated
Jun 22 closing price
Net Assets
10.98B
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

BBGSX vs VMGMX

BBGSX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
BBGSX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBGSX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. BBGSX (11B). VMGMX pays higher dividends than BBGSX: VMGMX (0.62) vs BBGSX (0.11). BBGSX was incepted earlier than VMGMX: BBGSX (11 years) vs VMGMX (15 years). BBGSX (0.66) is less costly to investors than VMGMX (0.07). BBGSX is a more actively managed with annual turnover of: 74.00 vs. VMGMX (17.00). BBGSX has a lower initial minimum investment than VMGMX: BBGSX (0) vs VMGMX (3000). BBGSX annual gain was more profitable for investors over the last year : 14.58 vs. VMGMX (11.76). VMGMX return over 5 years is better than : 31.10 vs. BBGSX (-2.65).
BBGSXVMGMXBBGSX / VMGMX
Total Expense Ratio0.340.07486%
Annual Report Gross Expense Ratio0.660.07943%
Fund Existence11 years15 years-
Gain YTD11.4189.952115%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets11B33.8B33%
Annual Yield % from dividends0.110.6218%
Returns for 1 year14.5811.76124%
Returns for 3 years41.6855.5375%
Returns for 5 years-2.6531.10-9%
Returns for 10 years98.56213.1346%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.09N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.35N/A
N/A
MFS Blended Research Value Equity R4